Home › Forums › General
Discussion forum for members to discuss anything to do with oncology pharmacy › Cabozantanib(Cometriq) Medullary Thyroid Cancer › Reply To: Cabozantanib(Cometriq) Medullary Thyroid Cancer
26/10/2021 at 11:04 am
#16070
Eleanor Puslow
Participant